Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Share Awards

27 Sep 2013 14:29

RNS Number : 1446P
Wilmington Group Plc
27 September 2013
 



WILMINGTON GROUP PLC

 

Share Awards

 

This notification is made in accordance with DTR 3.1.4(1)(a) and DTR 3.1.4(1)(b).

 

On 19 September 2013, awards over 248,645 ordinary shares in Wilmington Group plc (the "Company") were made under the Wilmington Group plc 2007 Performance Share Plan (the "Plan") to employees of the Group of which the following were made to Directors of the Company and other Persons Discharging Managerial Responsibility ("PDMRs"):

 

 Name of Director/PDMR Number of shares under the Award

 

Charles Brady (Chief Executive) 94,165

Neil Smith (Executive Director) 71,953

Tony Foye (Executive Director) 63,722

Linda Wake (PDMR) 18,805

No consideration was paid for the grant of the award which is structured as a conditional award.

 

The vesting of an award is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. The award will normally vest on the later of the third anniversary of grant and the determination of the performance conditions.

 

Richard Cockton

Company Secretary

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKODBNBKDOCB
Date   Source Headline
8th Jul 20193:54 pmRNSHolding(s) in Company
4th Jul 20197:00 amRNSExtension of debt facility
1st Jul 20195:11 pmRNSTotal Voting Rights
28th Jun 20197:00 amRNSWilmington plc Pre-close Trading Update
10th Jun 20194:41 pmRNSSecond Price Monitoring Extn
10th Jun 20194:35 pmRNSPrice Monitoring Extension
3rd Jun 20197:00 amRNSTotal Voting Rights
17th May 201912:13 pmRNSHolding(s) in Company
17th May 20199:21 amRNSHolding(s) in Company
16th May 20197:00 amRNSAppointment of Mark Milner as CEO
8th May 20197:00 amRNSChange of Company Secretary
3rd May 201911:18 amRNSDirector Declaration
1st May 20197:00 amRNSTotal Voting Rights
2nd Apr 20192:20 pmRNSTotal Voting Rights
1st Apr 20197:00 amRNSSAYE and Director/PDMR Shareholding
1st Mar 201911:00 amRNSHolding(s) in Company
1st Mar 201910:58 amRNSTotal Voting Rights
21st Feb 20197:00 amRNSResults for the six months ended 31 December 2018
14th Feb 201910:19 amRNSDirectorate Change Update
1st Feb 20193:53 pmRNSTotal Voting Rights
28th Jan 20194:44 pmRNSHolding(s) in Company
16th Jan 20197:00 amRNSDirectorate Change
2nd Jan 201910:33 amRNSTotal Voting Rights
14th Dec 20184:43 pmRNSNotification of Interim Results
3rd Dec 20187:00 amRNSTotal Voting Rights
14th Nov 20187:00 amRNSNew Joint Venture Agreement
1st Nov 20182:07 pmRNSResult of AGM
1st Nov 20187:00 amRNSTotal Voting Rights
1st Nov 20187:00 amRNSAGM Statement and Q1 Trading Update
17th Oct 20185:13 pmRNSHolding(s) in Company
1st Oct 20185:44 pmRNSDirector/PDMR Shareholding
1st Oct 201810:18 amRNSTotal Voting Rights
25th Sep 201812:29 pmRNSHolding(s) in Company
21st Sep 20183:13 pmRNSDirector/PDMR Shareholding
20th Sep 20183:19 pmRNSDirector/PDMR Shareholding
19th Sep 20182:12 pmRNSShare Awards
12th Sep 20187:00 amRNSFinancial results for the year ended 30 June 2018
3rd Sep 20189:00 amRNSTotal Voting Rights
28th Aug 201810:39 amRNSHolding(s) in Company
1st Aug 20189:00 amRNSTotal Voting Rights
19th Jul 20187:00 amRNSSale of ICP Credit Reporting Business
10th Jul 20184:24 pmRNSHolding(s) in Company
10th Jul 20184:19 pmRNSHolding(s) in Company
9th Jul 20182:23 pmRNSHolding(s) in Company
6th Jul 20187:00 amRNSTrading Statement
2nd Jul 201810:29 amRNSVoting Rights and Capital
1st Jun 20189:00 amRNSTotal Voting Rights
9th May 20187:00 amRNSCapital Markets Day
1st May 20187:00 amRNSTotal Voting Rights
3rd Apr 20187:00 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.